An improved method for the quantitative measurement of the angiotensin-converting enzyme inhibitor lisinopril in human plasma is presented. The assay is based on gas chromatography/negative ion chemical ionization mass spectrometry. The method involves solid phase extraction on C18 sorbent and deriv
Quantitative determination of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry
โ Scribed by H. J. Leis; G. Fauler; G. Raspotnig; W. Windischhofer
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 107 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0951-4198
No coin nor oath required. For personal study only.
โฆ Synopsis
A simple, highly accurate and precise method for the quantitative measurement of the angiotensinconverting enzyme inhibitor lisinopril in human plasma is presented. The assay is based on gas chromatography/negative ion chemical ionization mass spectrometry. The preparation of stable isotope labelled lisinopril for use as an internal standard is described. The method involves solid phase extraction on C18 sorbent and derivatization to the methyl diester-trifluoroacetamide derivatives. The detection limit was found to be 50 pg and a lower limit of quantification was reached down to 0.5 ng/mL plasma.
๐ SIMILAR VOLUMES
A method for the quantitative measurement of the non-steroidal anti-inflammatory drug ketoprofen in human plasma and urine is presented. The assay is based on gas chromatographylnegative ion chemical ionization mass spectrometry. The preparation of stable isotope-labelled ketoprofen for use as an in
A method for the quantitative determination of vitamin Klo,, (VK), an essential cofactor in the carboxylation of clotting factors, is presented. The assay is based on gas chromatography/electron impact mass/spectrometry. The preparation of deuterium-labelled vitamin I(,(,,, for use as an internal st